Antiadipogenic effects of aster glehni extract: In vivo and in vitro effects

Evidence-based Complementary and Alternative Medicine

Volumn 2013, Issue , 2013, Pages

  Lee, Heon Myung ^a   Yang, Gabsik ^a   Ahn, Tae Gue ^a   Kim, Myung Dong ^a   Nugroho, Agung ^b   Park, Hee Juhn ^b   Lee, Kyung Tae ^c   Park, Wansu ^d   An, Hyo Jin ^a  

^a Department of Computer and Electronic Physics   (South Korea)

^b Sangji University   (South Korea)

^c Kyung Hee University   (South Korea)

^d Gachon University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOBESITY AGENT; ASTER GLEHNI EXTRACT; CCAAT ENHANCER BINDING PROTEIN ALPHA; LEPTIN; LIPOPROTEIN LIPASE; LIVER X RECEPTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; PLANT EXTRACT; STEROL REGULATORY ELEMENT BINDING PROTEIN 1C; UNCLASSIFIED DRUG;

ADIPOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; ASTER GLEHNI; BODY WEIGHT; CELL DIFFERENTIATION; CELL STRAIN 3T3; CONCENTRATION RESPONSE; CONTROLLED STUDY; EPIDIDYMIS FAT; EXPERIMENTAL ANIMAL; GENE EXPRESSION; HERB; IN VITRO STUDY; IN VIVO STUDY; INTRAABDOMINAL FAT; LIPID DIET; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROADIPOCYTE; RANDOMIZED CONTROLLED TRIAL;

EID: 84880155292     PISSN: 1741427X     EISSN: 17414288     Source Type: Journal    
DOI: 10.1155/2013/859624     Document Type: Article

References (36)

1. World Health Organizatrion, What Are Overweight and Obesity, Facts About Overweight and Obesity 2012 Geneva, Switzerland Report of a WHO consultation on overweight and obesity
2. Rosini T. C., Silva A. S., Moraes C. D., Diet-induced obesity: rodent model for the study of obesity-related disorders. Revista Da Associação Médica Brasileira 2012 58 383 387
3. Lefterova M. I., Lazar M. A., New developments in adipogenesis. Trends in Endocrinology and Metabolism 2009 20 3 107 114 2-s2.0-62949236601 10.1016/j.tem.2008.11.005
4. Tontonoz P., Hu E., Spiegelman B. M., Regulation of adipocyte gene expression and differentiation by peroxisome proliferator activated receptor γ Current Opinion in Genetics and Development 1995 5 5 571 576 2-s2.0-0029154635 10.1016/0959-437X(95)80025-5
5. Brown M. S., Goldstein J. L., The SREBP pathway: regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor. Cell 1997 89 3 331 340 2-s2.0-0030941803 10.1016/S0092-8674(00)80213-5
6. Linehan C., Gupta S., Samali A., O'Connor L., Bisphenol a-mediated suppression of lpl gene expression inhibits triglyceride accumulation during adipogenic differentiation of human adult stem cells. PLoS ONE 2012 7 5 e36109 10.1371/journal.pone.0036109
7. Seo J. B., Moon H. M., Kim W. S., Lee Y. S., Jeong H. W., Yoo E. J., Ham J., Kang H., Park M.-G., Steffensen K. R., Stulnig T. M., Gustafsson J.-Å., Park S. D., Kim J. B., Activated liver x receptors stimulate adipocyte differentiation through induction of peroxisome proliferator-activated receptor γ expression. Molecular and Cellular Biology 2004 24 8 3430 3444 2-s2.0-11144356074 10.1128/MCB.24.8.3430-3444.2004
8. Friedman J. M., Halaas J. L., Leptin and the regulation of body weight in mammals. Nature 1998 395 6704 763 770 2-s2.0-0032558725 10.1038/27376
9. Heck A. M., Yanovski J. A., Calis K. A., Orlistat, a new lipase inhibitor for the management of obesity. Pharmacotherapy 2000 20 3 270 279 2-s2.0-0034048643
10. Luque C. A., Rey J. A., Sibutramine: a serotonin-norepinephrine reuptake-inhibitor for the treatment of obesity. Annals of Pharmacotherapy 1999 33 9 968 978 2-s2.0-0032852016 10.1345/aph.18319
11. Kim S., Jin Y., Choi Y., Park T., Resveratrol exerts anti-obesity effects via mechanisms involving down-regulation of adipogenic and inflammatory processes in mice. Biochemical Pharmacology 2011 81 11 1343 1351 2-s2.0-79955611314 10.1016/j.bcp.2011.03.012
12. Lee Y. S., Kim W. S., Kim K. H., Yoon M. J., Cho H. J., Shen Y., Ye J.-M., Lee C. H., Oh W. K., Kim C. T., Hohnen-Behrens C., Gosby A., Kraegen E. W., James D. E., Kim J. B., Berberine, a natural plant product, activates AMP-activated protein kinase with beneficial metabolic effects in diabetic and insulin-resistant states. Diabetes 2006 55 8 2256 2264 2-s2.0-33749336146 10.2337/db06-0006
13. Kim T., Korean Plant Resources 1996 Publishing Center of Seoul National University
14. Nugroho A., Kim M. H., Choi J., Choi J. S., Jung W. T., Lee K. T., Park H. J., Phytochemical studies of the phenolic substances in Aster glehni extract and its sedative and anticonvulsant activity. Archives of Pharmacal Research 2012 35 423 430 10.1007/s12272-012-0304-7
15. Kim M.-H., Nugroho A., Choi J., Park H.-J., The extract of Aster glehni leaves rich in caffeoylquinic acids prevents atherogenic index, oxidative stress, and body weight increase in high-fat diet-induced rats. Korean Journal of Pharmacognosy 2011 42 1 54 60 2-s2.0-81855227197
16. van Tits L. J. H., Arioglu-Oral E., Sweep C. G. J., Smits P., Stalenhoef A. F. H., Tack C. J., Anti-inflammatory effects of troglitazone in nondiabetic obese subjects independent of changes in insulin sensitivity. Netherlands Journal of Medicine 2005 63 7 250 255 2-s2.0-23844523800
17. Pischon T., Nöthlings U., Boeing H., Obesity and cancer. Proceedings of the Nutrition Society 2008 67 2 128 145 2-s2.0-42149163704 10.1017/S0029665108006976
18. Ono Y., Hattori E., Fukaya Y., Imai S., Ohizumi Y., Anti-obesity effect of Nelumbo nucifera leaves extract in mice and rats. Journal of Ethnopharmacology 2006 106 2 238 244 2-s2.0-33646773975 10.1016/j.jep.2005.12. 036
19. Seo J. B., Choe S. S., Jeong H. W., Park S. W., Shin H. J., Choi S. M., Park J. Y., Choi E. W., Kim J. B., Seen D. S., Jeong J.-Y., Lee T. G., Anti-obesity effects of Lysimachia foenum-graecum characterized by decreased adipogenesis and regulated lipid metabolism. Experimental and Molecular Medicine 2011 43 4 205 215 2-s2.0-79955661879 10.3858/emm.2011.43.4.025
20. Sharpe P. A., Blanck H. M., Williams J. E., Ainsworth B. E., Conway J. M., Use of complementary and alternative medicine for weight control in the United States. Journal of Alternative and Complementary Medicine 2007 13 2 217 222 2-s2.0-34047184823 10.1089/acm.2006.6129
21. Rosen E. D., Walkey C. J., Puigserver P., Spiegelman B. M., Transcriptional regulation of adipogenesis. Genes and Development 2000 14 11 1293 1307 2-s2.0-0034214246
22. Wu Z., Puigserver P., Spiegelman B. M., Transcriptional activation of adipogenesis. Current Opinion in Cell Biology 1999 11 6 689 694 2-s2.0-0032727505 10.1016/S0955-0674(99)00037-X
23. Tontonoz P., Spiegelman B. M., Fat and beyond: the diverse biology of PPAR γ Annual Review of Biochemistry 2008 77 289 312 2-s2.0-50649097541 10.1146/annurev.biochem.77.061307.091829
24. Schoonjans K., Peinado-Onsurbe J., Lefebvre A.-M., Heyman R. A., Briggs M., Deeb S., Staels B., Auwerx J., PPAR α and PPAR γ activators direct a distinct tissue-specific transcriptional response via a PPRE in the lipoprotein lipase gene. EMBO Journal 1996 15 19 5336 5348 2-s2.0-0029791412
25. Yeh W.-C., Cao Z., Classon M., McKnight S. L., Cascade regulation of terminal adipocyte differentiation by three members of the C/EBP family of leucine zipper proteins. Genes and Development 1995 9 2 168 181 2-s2.0-0028878375
26. Brun R. P., Kim J. B., Hu E., Altiok S., Spiegelman B. M., Adipocyte differentiation: a transcriptional regulatory cascade. Current Opinion in Cell Biology 1996 8 6 826 832 2-s2.0-0030560633 10.1016/S0955-0674(96)80084-6
27. Kim J. B., Spiegelman B. M., ADD1/SREBP1 promotes adipocyte differentiation and gene expression linked to fatty acid metabolism. Genes and Development 1996 10 9 1096 1107 2-s2.0-0030007427
28. Fajas L., Schoonjans K., Gelman L., Kim J. B., Najib J., Martin G., Fruchart J.-C., Briggs M., Spiegelman B. M., Auwerx J., Regulation of peroxisome proliferator-activated receptor γ expression by adipocyte differentiation and determination factor 1/sterol regulatory element binding protein 1: implications for adipocyte differentiation and metabolism. Molecular and Cellular Biology 1999 19 8 5495 5503 2-s2.0-0032793068
29. Kim J. B., Wright H. M., Wright M., Spiegelman B. M., ADD1/SREBP1 activates PPAR γ through the production of endogenous ligand. Proceedings of the National Academy of Sciences of the United States of America 1998 95 8 4333 4337 2-s2.0-0032516081 10.1073/pnas.95.8.4333
30. Lu T. T., Repa J. J., Mangelsdorf D. J., Orphan nuclear receptors as eLiXiRs and FiXeRs of sterol metabolism. The Journal of Biological Chemistry 2001 276 41 37735 37738 2-s2.0-0035851188
31. Chawla A., Boisvert W. A., Lee C.-H., Laffitte B. A., Barak Y., Joseph S. B., Liao D., Nagy L., Edwards P. A., Curtiss L. K., Evans R. M., Tontonoz P., A PPAR γ -LXR-ABCA1 pathway in macrophages is involved in cholesterol efflux and atherogenesis. Molecular Cell 2001 7 1 161 171 2-s2.0-17744376173 10.1016/S1097-2765(01)00164-2
32. Friedman J. M., Leptin and the Regulation of Body Weight. The Keio Journal of Medicine 2011 60 1 1 9 2-s2.0-79955701330 10.2302/kjm.60.1
33. Zhou C. J., Huang S., Liu J. Q., Qiu S. Q., Xie F. Y., Song H. P., Li Y. S., Hou S. Z., Lai X. P., Sweet tea leaves extract improves leptin resistance in diet-induced obese rats. Journal of Ethnopharmacology 2013 145 1 386 392 10.1016/j.jep.2012.09.057
34. An H.-J., Rim H.-K., Suh S.-E., Jeong H.-J., Um J.-Y., Hong S.-H., Kim H.-M., Gamiwalbitang, composed of four herbs, controls body weight increase and lipid level elevation induced by a high-fat diet in mice. Immunopharmacology and Immunotoxicology 2010 32 2 307 312 2-s2.0-77952143763 10.3109/08923970903335108
35. Tilg H., Moschen A. R., Adipocytokines: mediators linking adipose tissue, inflammation and immunity. Nature Reviews Immunology 2006 6 10 772 783 2-s2.0-33748992313 10.1038/nri1937
36. Harrison H. F. Jr., Mitchell T. R., Peterson J. K., Wechter W. P., Majetich G. F., Snook M. E., Contents of caffeoylquinic acid compounds in the storage roots of sixteen sweetpotato genotypes and their potential biological activity. Journal of the American Society for Horticultural Science 2008 133 4 492 500 2-s2.0-47749096317